European Commission Approves AstraZeneca’s Truqap With Faslodex in ER-Positive Breast Cancer
NEW YORK – AstraZeneca on Thursday said the European Commission approved its AKT inhibitor Truqap (capivasertib) in combination with Faslodex …Read More
The Heartbeat of World events
NEW YORK – AstraZeneca on Thursday said the European Commission approved its AKT inhibitor Truqap (capivasertib) in combination with Faslodex …Read More